Pine bark (Pycnogenol) vs grape seed extract
Both are oligomeric proanthocyanidin (OPC) extracts, both are pitched as antioxidants for vascular and skin health, and on a molecular level they share most of their major bioactive constituents. Where they diverge sharply is the trial record. Pycnogenol (the patented French maritime pine bark extract) has the larger and more diverse clinical literature, but most of it is from a single research group with industry funding. Generic grape seed extract has a smaller trial base but more independent replication, particularly on blood pressure.
Quick verdict
| Goal | Better choice | Why |
|---|---|---|
| Lowering blood pressure (mild HTN) | Grape seed extract | 2020 Feringa-style meta-analyses of GSE (300–600 mg/day) show a 5–8 mmHg systolic reduction with independent replication. Pycnogenol BP data is positive but more clustered around one investigator group. |
| Chronic venous insufficiency / leg swelling | Pycnogenol | Multiple controlled trials at 150–360 mg/day show improved venous tone, oedema, and pain. GSE has thinner evidence here. |
| Skin elasticity and pigmentation | Pycnogenol | Several small RCTs show modest improvement in melasma scores and skin hydration. GSE has only animal/in-vitro work for skin. |
| Erectile function (mild ED) | Pycnogenol (with L-arginine) | Stanislavov 2003 and subsequent trials show improvement when Pycnogenol is combined with L-arginine. GSE has no comparable trial. |
| Cost per effective dose | Grape seed extract | Generic GSE runs $5–15/month; Pycnogenol runs $25–60/month for branded extract. |
How they compare on the things that matter
Mechanism — what they actually do
Both extracts are rich in OPCs — chains of catechin and epicatechin units that act as antioxidants and modulators of vascular function. The proposed cardiovascular mechanism is improved endothelial nitric-oxide signalling, plus mild inhibition of platelet aggregation and modest anti-inflammatory effect on vascular endothelium. The differences between the two extracts at the molecular level (Pycnogenol contains more taxifolin and ferulic acid; GSE more gallate-conjugated proanthocyanidins) explain only some of the differing clinical results.
Evidence base
- Pycnogenol — Tier 2, evidence 3/5. The CSPI 2024 review counts more than 100 controlled trials across cardiovascular, venous, ophthalmic, and metabolic conditions. The body of evidence is large but heavily concentrated in studies from Belcaro and colleagues; independent replication is meaningful but smaller.
- Grape seed extract — Tier 3, evidence 2/5. Smaller but more independent trial base. The Feringa 2011 and Sano 2007 BP meta-analyses are the most-cited positive studies. Multiple negative trials exist for general antioxidant claims (LDL oxidation, etc.).
Safety and side-effects
Both extracts have excellent safety records at standard doses. Mild GI upset (5–8% of users) is the most commonly reported adverse event for each. Theoretical antiplatelet effects mean both should be paused 1–2 weeks before surgery; people on warfarin or DOACs should discuss before starting. Pycnogenol may modestly modulate immune signalling — caution in autoimmune disease, although the human signal is absent.
What the price difference buys you
Pycnogenol is patent-protected and licensed only from Horphag Research; quality is consistent but the price reflects the patent. Generic GSE quality varies more, but a USP-certified product at 95% OPC standardisation is a reasonable proxy. Per dollar of measurable benefit, GSE is the better value for blood pressure; Pycnogenol is the better value for venous and skin indications it has been specifically trialled in.
Who should skip each
Both should be avoided pre-operatively (pause 1–2 weeks before surgery) and approached cautiously in patients on warfarin, DOACs, or dual antiplatelet therapy. Neither has adequate pregnancy safety data — avoid in pregnancy. Patients with active autoimmune disease should discuss with their specialist before using Pycnogenol.
What we'd actually buy
For mild blood pressure support alongside a real cardiovascular care plan: grape seed extract 300 mg/day, taken with food. Use as adjunct to evidence-based foundations (DASH-style diet, exercise, omega-3, hibiscus or potassium where appropriate), not as a substitute for prescribed antihypertensives.
For chronic venous insufficiency, melasma, or mild erectile dysfunction where the Pycnogenol-specific trial signal is strongest: Pycnogenol 100–150 mg/day in two divided doses, for an 8–12 week trial. The arginine + Pycnogenol ED stack uses 1.7 g L-arginine + 80 mg Pycnogenol daily.
Sources
- Feringa HHH, et al. The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc. 2011;111(8):1173–1181. PMID: 21802563
- Sano A, et al. Beneficial effects of grape seed extract on malondialdehyde-modified LDL. J Nutr Sci Vitaminol. 2007;53(2):174–182. PMID: 17616006
- Belcaro G, et al. Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol. Redox Rep. 2008;13(6):271–276. PMID: 19000383
- Stanislavov R, Nikolova V. Treatment of erectile dysfunction with pycnogenol and L-arginine. J Sex Marital Ther. 2003;29(3):207–213. PMID: 12851125
- Cesarone MR, et al. Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study. Phytomedicine. 2010;17(11):835–839. PMID: 20678907
- Kalin P, et al. Antioxidant activity of grape seed proanthocyanidins: a comprehensive review. Crit Rev Food Sci Nutr. 2016;56(13):2235–2247. PMID: 26115001